Lancet. 2017 Jul 1;390(10089):85-94. doi: 10.1016/S0140-6736(16)00645-0. Epub 2017 Jan 13.
PMID:28089471
[[Translated article]]Update of the Spanish Consensus Document on Infantile Hemangioma.
Baselga E, Bernabeu-Wittel J, Betlloch Mas I, Campos Domínguez M, Carrasco Sanz Á, Del Boz J, de Lucas Laguna R, Del Pozo Losada J, Hernández Martín Á, Jiménez Montañés L, López Gutiérrez JC, Martín-Santiago A, Redondo P, Torrelo Fernández A, Vicente Villa A.
Actas Dermosifiliogr. 2025 Jun 24:S0001-7310(25)00461-2. doi: 10.1016/j.ad.2025.06.017. Online ahead of print.
PMID:40570952
Propranolol Therapy in Infantile Hemangioma: It Is Not Just About the Beta.
Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A.
N Engl J Med. 2008 Jun 12;358(24):2649-51. doi: 10.1056/NEJMc0708819.
PMID:18550886
Successful treatment of infantile hemangioma with high risk of severe sequelae by microneedle radiofrequency.
Qiu Y, Qiao C, Yang J, Gao W, Lin X.
Dermatol Ther. 2020 Nov;33(6):e13953. doi: 10.1111/dth.13953. Epub 2020 Aug 11.
PMID:32614134
Is Infantile Hemangioma a Neuroendocrine Tumor?
Kaulanjan-Checkmodine P, Oucherif S, Prey S, Gontier E, Lacomme S, Loot M, Miljkovic-Licina M, Cario M, Léauté-Labrèze C, Taieb A, Moisan F, Rezvani HR.
Int J Mol Sci. 2022 May 5;23(9):5140. doi: 10.3390/ijms23095140.
PMID:35563552
Oral atenolol compared to oral propranolol for infantile hemangioma.
Meza Viteri V, Aranibar L.
Medwave. 2023 Dec 7;23(11):e2753. doi: 10.5867/medwave.2023.11.2753.
PMID:38061014
Our experience with propranolol for infantile hemangioma.
Wu Y, Zhao P, Song W, Lu W, Dai T, Wang L.
Skin Res Technol. 2023 Apr;29(4):e13310. doi: 10.1111/srt.13310.
PMID:37113082
Severe hypoglycemia in propranolol treatment for infantile hemangiomas.
Morimoto A, Ozeki M, Sasaki S, Baba N, Kuwano Y, Kaneko T.